e-learning
resources
Courses
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Empyema: How to prevent progression to stage III disease
Philippe Astoul (Marseille, France)
Source:
ERS Course 2019 - Thoracoscopy and Pleural Techniques
Number:
12
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Philippe Astoul (Marseille, France). Empyema: How to prevent progression to stage III disease. ERS Course 2019 - Thoracoscopy and Pleural Techniques
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
How to prevent progression to stage III disease
Source: International Congress 2016 – An update on pleural empyema diagnostics and treatment
Year: 2016
Stage IV sarcoidosis: comparison of survival with the general population and causes of death
Source: Eur Respir J 2011; 38: 1368-1373
Year: 2011
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Managing end stage disease in ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Managing end stage disease in ILDs
Source: ERS Course 2016
Year: 2016
Monitoring disease progression in COPD patients: one step beyond!
Source: Eur Respir J 2014; 43: 665-667
Year: 2014
COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Pulmonary malakoplakia: a rare presentation mimicking extensive stage IV lung cancer
Source: Eur Respir J 2011; 38: 983-985
Year: 2011
Systemic inflamation and prognosis in lung cancer stage I-II
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Time lost for diagnostics of lung carcinoma related to disease stage and prognosis
Source: Eur Respir J 2004; 24: Suppl. 48, 297s
Year: 2004
Cytomegalovirus: an unrecognised potential contributor to cystic fibrosis disease progression?
Source: Eur Respir J, 53 (4) 1801727; 10.1183/13993003.01727-2018
Year: 2019
Heterogeneity of stage III and its implication on treatment
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
How to manage a patient with COPD - early identification and how to prevent progression
Source: ERS Satellites 2021
Year: 2021
Comorbidities in stage IV COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
NSCLC stage IV
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
The role of determining the levels of collagen type IV in the management of patients with severe chronic obstructive pulmonary disease – Focus on roflumilast
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage?
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Late stage of experimental pulmonary fibrosis is modulated by collagen V
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept